Efficacy of sclerotherapy on cirrhotic patients with ruptured or non-ruptured risky esophageal varices. Comparative study of sclerotherapy and PTO.:Comparative Study of sclerotherapy and PTO

概要

論文の詳細を見る
One course of sclerotherapy or percutaneous transhepatic obliteration were performed to cirrhotics with esophageal varices electively or prophylactically, and we calculated the cumulative survival rate and the cumulative bleeding rate of esophageal varices and upper gastrointestinal tract up two years after treatment. Comparing with PTO group, both elective and prophylactic sclerotherapy groups show better survival rate and lower bleeding rate. Serial endoscopic findings indicate that esophageal varices are developed six months after eradication and gradually grow up. Low grade fever and microscopic hematuria are occured accompanied with sclerotherapy but there is no lifethreatening complication. Sclerotherapy is advocated as the first line of treatment for cirrhotlc patients with ruptured varices or non-ruptured risky varices.